ICEECE2012 Poster Presentations Female Reproduction (99 abstracts)
1Moscow Regional Research & Clinical Institute named by MF Vladimirsky, Moscow, Russian Federation; 21st Moscow State Medical University named by IM Sechenov, Moscow, Russian Federation; 3Federal Endocrinology Research Centre, Moscow, Russian Federation.
We estimated androgen status at 111 female patients (pts) with HH before and after hormonal therapy (HT) by estadiol 2 mg+dydrogesterone 10 mg in sequence manner not <12 months. Median age of pts was 28 y.o., mean duration of HH 6.2 year, isolated HH n=56 group 1, HH as a part of hypopituitarism n=55 group 2, 45 healthy women of the same age were included in control group. Total T, SHBG and DHEA-S levels were measured, free T levels were calculated using standard formula. To estimate the quality of life the General Health Questionnaire (GHQ-28) was used.
Initially in both 1 and 2 groups total and free T levels were significantly lower compared to the controls (P<0.05), decrease was more appreciable in group 2 (see Table 1). DHEA-S levels were significantly lower in group 2 but not in group 1 compared with controls. There are some data that estrogen therapy can provoke depression of androgen levels. During HT the total and free T levels did not changed considerably so position had not worsened. DHEA-S levels even increased and the difference was statistically significant in group 2.
Total T levels positively correlated with the quality of sleep (r=0.47; P=0.02), social and physical activities (r=0.54; P=0.000003) and negatively correlated with depression (r=−0.67; P<0.001) and nervousness (r=−0.57; P=0.0001). Free testosterone levels positively correlated with the positive emotional reactions (r=0.33; P=0.04), social and physical activities (r=0.6; P<0.001), quality of sleep (r=0.46; P=0.003) and negatively correlated with depression (r=−0.7; P<0.001) and nervousness (r=−0.6; P<0.001). DHEA-S levels positively correlated with the positive emotional reactions (0.46; P=0.003), social and physical activities (r=0.5; P<0.001), quality of sleep (r=0.45; P=0.003), daily activities (r=0.56, P<0.001) and negatively correlated with depression (r=−0.55; P<0.001) and nervousness (r=−0.45; P=0.004).
Thus, hypogonadotropic hypogonadism is the disease associated androgen deficit with which influences on quaity of life. Hypoandrogenemia is more severe in patients with hypopituitarism
Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.
Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Group 1 (n=56) | Group 2 (n=55) | ||||
Parameter | Before HT | After HT | Before HT | After HT | Control group |
Total T (nmol/l) | 0.95 (0.7; 1.2) | 0.85 (0.6; 1.0) | 0.1 (0.1; 0.2) | 0.1 (0.08; 0.3) | 1.05 (0.8; 1.4) |
Free T (pmol/l) | 7.0 (4.8; 9.0) | 6.9 (5.5; 8.3) | 1.4 (0.6; 2.0) | 0.75 (0.4; 1.6) | 10.0 (7.0; 16.0) |
DHEA-S (nmol/l) | 3590 (2747; 6630) | 5001 (3430; 6510) | 128 (73; 850) | 270 (94; 1357) | 5590 (4030; 6630) |